AI Therapeutics Overview
- Founded
- 2013

- Status
- Private
- Employees
- 16

- Latest Deal Type
- Debt - PPP
- Investors
- 4
AI Therapeutics General Information
Description
Developer of precision therapeutics technology designed to treat cancer and rare diseases. The company's technology accelerates drug development by deploying technologies including next-gen sequencing, genome editing, chemical genomics, and combinational drug screening with deep learning to match clinical drugs, enabling doctors to treat diseases by providing significant therapeutic benefits for patients.
Contact Information
- 530 Old Whitfield Street
- Guilford, CT 06437
- United States
AI Therapeutics Timeline
AI Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Debt - PPP | 03-May-2020 | 0000 | Completed | Startup | ||
4. Later Stage VC (Series C) | 30-Mar-2017 | 0000 | 0000 | 00000 | Completed | Startup |
3. Corporate (Series B) | 03-Feb-2016 | 0000 | 0000 | 0000 | Completed | Startup |
2. Early Stage VC (Series A) | 06-Jun-2013 | $20M | $20M | 0000 | Completed | Startup |
1. Accelerator/Incubator | Completed | Startup |
AI Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series B | 00,000,000 | 00.000000 | 00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
Series A | 25,250,000 | $0.000100 | 8% | $0.8 | $0.8 | 1x | $0.8 | 30.53% |
AI Therapeutics Comparisons
Industry
00000000
0000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAI Therapeutics Competitors (37)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Recursion Pharmaceuticals | Venture Capital-Backed | Salt Lake City, UT | 000 | 00000 | 00000000000 | 00000 |
0000000 0000000000 | Formerly VC-backed | Richmond, CA | 000 | 000.00 | 00000000 | 000.00 |
0000000 | Venture Capital-Backed | Toronto, Canada | 00 | 000.00 | 00000 | 000.00 |
000000 00000000000 | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
000000 00000000000 | Corporation | Plymouth Meeting, PA | 000 | 000.00 | 00000000 | 000.00 |
AI Therapeutics Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Tian Xu Ph.D | Co-Founder & Scientific Advisor | ||
Paul Beckett Ph.D | Senior Director of Drug Discovery |
AI Therapeutics Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
George Rehm JD | Self | Board Member | 000 0000 |
Gregg Fergus | 4Catalyzer | Board Member | 000 0000 |
Jonathan Rothberg Ph.D | Self | Board Member | 000 0000 |
AI Therapeutics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAI Therapeutics Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Yonghua Capital | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
YuanBio Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Xiphos Bio | Corporation | Minority | 000 0000 | 000000 0 | |
4Catalyzer | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |